Prenetics Global posts Q3 revenue surge but widens loss outlook
Prenetics Global reported third‑quarter 2026 revenue of $64.1 million, a year‑over‑year increase of over 170%. The quarter ended with a net loss of $25.4 million and the company expanded its second‑half adjusted EBITDA loss guidance to $30‑35 million. Management highlighted strong growth spending and a 64% gross margin, while investors pushed the share price down 37‑42.5% on the widened loss outlook.
Why it matters
The raised loss guidance triggered a sharp stock decline, reflecting investor concern over near‑term profitability. The updated outlook also signals higher cash burn before the company expects its growth investments to pay off.
Key facts
- 1Q3 2026 revenue was $64.1 million. tradingview.com
- 2Revenue grew 228% year‑over‑year. tradingview.com
- 3Revenue grew 171.6% year‑over‑year. seekingalpha.com
- 4Net loss for the quarter was $25.4 million. tradingview.com
- 5Adjusted EBITDA loss guidance for the second half of 2026 was expanded to $30‑35 million. tradingview.com
- 6Adjusted EBITDA loss guidance for the second half of 2026 was $17‑22 million in a separate statement. finance.yahoo.com
Open questions
- YoY revenue growth reported as 228% versus 171.6%.
- Second‑half adjusted EBITDA loss guidance given as $30‑35 million and $17‑22 million.
Summary written by AlphAI AI Desk from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.